Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Nigale Biomedical is a prominent Chinese medical technology company focused on the development and manufacture of blood collection and processing systems. Established in 1994, the company provides a comprehensive range of products including automated apheresis machines, plasma separators, and specialized consumables for blood centers and clinical settings. Their technology is central to the collection of source plasma for the fractionation industry and for therapeutic procedures such as plasma exchange. Headquartered in Chengdu, Nigale is a key player in the global transfusion medicine market, exporting its solutions to numerous countries across Asia, Africa, and South America. The company is publicly listed on the NEEQ and maintains rigorous quality standards through ISO and GMP certifications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Nigale Biotechnology.